Bermuda-based consolidation vehicle is the third incarnation of Sir Clive Cowdery’s acquisitive Resolution

Resolution Life, an insurance consolidation vehicle founded by Sir Clive Cowdery, has completed a $3bn fundraising and added several of the investors who contributed, including JPMorgan and KKR, to its board.

Bermuda-based Resolution Life, founded in 2017, is Cowdery’s latest vehicle for buying and merging insurers.

A previous UK company, also called Resolution, acquired a series of businesses in the 2000s before merging with Britannic Group and then being sold to Hugh Osmond’s Pearl Group, later becoming Phoenix Group.

Cowdery relaunched the Resolution business a second time, buying Friends Life in 2009 and adding other businesses from Axa Sun Life and Bupa. This was then sold to Aviva in 2014.

This latest, third incarnation has acquired $5.7bn of life insurance policies from US insurer Symetra, and in October 2018, agreed to buy various insurance businesses from AMP in Australia and New Zealand for A$3bn.

In a statement on November 18, Resolution Life said it has raised $3bn from investors to finance further deals.

Representatives from JPMorgan, KKR, the Nippon Life Insurance Company, Singaporean sovereign wealth fund Temasek, and USS, the UK’s largest pension fund, will join its board — alongside an unnamed Middle Eastern sovereign fund.

Credit Suisse Asset Management acted as a placement agent on the fundraising.

Cowdery, who is executive chair of the company, said: “Resolution Life will continue to grow and release trapped capital and stranded costs for life insurers across a number of markets. I am delighted to welcome our cornerstone investors onto our board.”

 

Source: Financial News

Can’t stop reading? Read more

Platinum Equity considers $2bn Club Car sale 

Platinum Equity considers $2bn Club Car sale 

Private equity firm Platinum Equity has hired advisers from investment bank Goldman Sachs in exploring a sale of golf cart manufacturer Club Car that could value the company at more than $2bn.  The report cites unnamed sources in confirming that Platinum Equity is in...

read more
IFF to sell pharma unit to France’s Roquette in $2.85bn

IFF to sell pharma unit to France’s Roquette in $2.85bn

International Flavors & Fragrances said on Tuesday it would sell its pharma solutions business to French plant-based ingredients maker Roquette in a deal valued at $2.85 billion, as it looks to focus on higher-margin businesses. Get the week's top news delivered...

read more